Control Bionics Ltd Ordinary Shares CBL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.04
- Day Range
- A$0.04–0.04
- 52-Week Range
- A$0.03–0.15
- Bid/Ask
- A$0.04 / A$0.05
- Market Cap
- A$7.34 Mil
- Volume/Avg
- 35,250 / 49,515
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.80
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Control Bionics Ltd is engaged in the business of healthcare devices. It is engaged in the development, commercialization, and sale of assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.controlbionics.com
Valuation
|
Metric
|
CBL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.81 |
Price/Sales | 0.80 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CBL
|
|---|---|
Quick Ratio | 2.80 |
Current Ratio | 3.34 |
Interest Coverage | −3,926.83 |
Quick Ratio
CBL
Profitability
|
Metric
|
CBL
|
|---|---|
Return on Assets (Normalized) | −48.18% |
Return on Equity (Normalized) | −56.21% |
Return on Invested Capital (Normalized) | −55.64% |
Return on Assets
CBL
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Rbhcstyy | Yfmxqjn | $185.5 Bil | |
SYK
| Stryker Corp | Djwsqkztvr | Qkqy | $128.2 Bil | |
MDT
| Medtronic PLC | Kmzlypf | Yyzkj | $106.7 Bil | |
BSX
| Boston Scientific Corp | Vhnpwrf | Tmmdqdl | $99.0 Bil | |
DXCM
| DexCom Inc | Vmhfnlvhpr | Dnfhs | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Ljgrnbjm | Stjwdt | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Bjjwxvvthd | Vbvg | $24.9 Bil | |
ALGN
| Align Technology Inc | Hzlztbwx | Rtwsrfb | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Xktlqxt | Xfsyz | $18.9 Bil | |
PODD
| Insulet Corp | Lxnrcftgb | Zkwrcn | $11.7 Bil |